Form 4 for DERM Journey Medical Corp
Accepted 2025-06-20 00:00:00 ET · period of report 2025-06-17 · accession 0001104659-25-061155 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-20 | 2025-06-17 | DERM | Benesch Joseph | CFO | A - Grant | $0.00 | +28.9K | 232.5K | +14% | $0 |
| D | 2025-06-20 | 2025-06-17 | DERM | Benesch Joseph | CFO | A - Grant | $0.00 | +41.9K | 41.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.0001 par value | 2025-06-17 | A | A | 28,907 | $0.00 | 232,464 | D | — | — | (F1) On June 17, 2025, the reporting person was granted 28,907 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 9,636 shares on January 1, 2026, 9,636 shares on January 1, 2027 and 9,635 shares on January 1, 2028. (F2) Includes restricted stock units, which vest over various time periods. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-06-17 | A | A | 41,860 | $0.00 | 41,860 | D | $6.31 · — to 2035-06-17 | 41,860 Common Stock, $0.0001 par value | (F3) On June 17, 2025, the reporting person was granted 41,860 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 13,953 shares on January 1, 2026, 13,953 shares on January 1, 2027 and 13,954 shares on January 1, 2028. |